Clinical Trials in Atlanta

Showing 4441-4460 of 14,667 trials

Duvelisib Exposure to Enhance Immune Profiles of T Cells in Patients With Recurrent or Refractory Diffuse Large B-Cell Lymphoma, DEEP T CELLS Study

NCT04890236

This early phase I trial investigates how well duvelisib exposure before CAR-T cell manufacturing works to enhance immune profiles of T cells in patients with diffuse large B-cell lymphoma that has come back (recurrent) or does not respond to treatment (refractory). Duvelisib, an oral phosphoinositide 3-kinase (PI3K) inhibitor, may favorably change a patient's T cells to make them more efficient and have a longer duration for manufacturing of CAR-T cells.

Recurrent Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma

Emory University4 participantsStarted Jan 2022

Atlanta, Georgia, United States • Chicago, Illinois, United States

COMPLETEDPhase 2< 1 mile

ACP-104 in Acutely Psychotic Subjects With Schizophrenia

NCT00490516

This is a randomized, double-blind, placebo-controlled parallel-group, 6-week study, evaluating two dose levels of ACP-104 or Placebo twice a day in patients with schizophrenia who are experiencing an acute psychotic episode.

Schizophrenia

ACADIA Pharmaceuticals Inc.247 participantsStarted Jun 2007

Anaheim, California, United States • Costa Mesa, California, United States • Covina, California, United States +18 more locations

Duvelisib Exposure to Enhance Immune Profiles of T Cells in Patients With Recurrent or Refractory Diffuse Large B-Cell Lymphoma, DEEP T CELLS Study

ACP-104 in Acutely Psychotic Subjects With Schizophrenia

Find Trials by Condition in Atlanta

Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting

Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple Myeloma

Perioperative Stress Hyperglycemia in General and Vascular Surgery Patients

Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)

A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSC

CLUSTER Trial for Outbreak Detection and Response

Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Subjects With Moderate COVID-19

ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

International EXPAND Heart Pivotal Trial

Saypha® VOLUME Lidocaine for Midface Augmentation

Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045)

Non-Complex Biliary Stones DSC vs ERC

A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study

Examination of Myopia Progression and Soft Bifocal Contact Lens Myopia Control

The Gilenya Pregnancy Registry

Extension to the MAGNIFY MS Trial on Mavenclad® (Magnify MS Extension)

International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia